New MRI-Ultrasound fusion aims to sharpen prostate cancer detection
NCT ID NCT05064111
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new software that combines MRI images with real-time ultrasound to guide prostate biopsies. The goal is to help doctors more accurately detect and locate aggressive prostate cancer early. About 100 men scheduled for a standard prostate biopsy will take part. The research focuses on improving diagnosis, not on treating the cancer itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- image fusion software
- What this could lead to
- If successful, this could make prostate cancer biopsies more accurate, helping doctors find aggressive cancers earlier and choose better treatments.
- What could go wrong
- This is an early-stage study testing a software add-on, not a new treatment. The trial is currently suspended, and the software is not yet FDA-approved, so results may not lead to immediate changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Arizona
Tucson, Arizona, 85724, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can surgery boost control of spread prostate cancer?
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks